The Drug Monitoring, Barbiturates, Quantitative, Urine test contains 1 test with 6 biomarkers.
Drug Monitoring, Barbiturates, Quantitative, Urine
Drug Monitoring, Barbiturates, Quantitative, Urine - The barbiturate class of drugs are substances that are traditionally classified as sedatives. Their principle uses are to calm the patient, produce drowsiness, and/or promote sleep. They are central nervous system (CNS) depressants. The test is a definitive assay using gas chromatography mass spectroscopy (GC/MS) methodology. Therapeutic urine drug monitoring of the barbiturates is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.
If you require medMATCH for this order code, you must also order code 39158 - Prescribed Drugs, medMATCH®. If 39158 is ordered, all Drug Monitoring order codes will be treated as medMATCH.
If this test code is not ordered with 39158, all medMATCH result codes will be DNR’d.
Amobarbital, Butalbital, Pentobarbital, Secobarbital, Phenobarbital
Amobarbital <100 ng/mL
Butalbital <100 ng/mL
Pentobarbital <100 ng/mL
Secobarbital <100 ng/mL
Phenobarbital <100 ng/mL
Prescription Drug Monitoring,Pain Management